| Publication | Purpose | Published date |
|---|---|---|
| Survey of fertility treatments: survey one - PCT Commissioning Managers, ABACUS | To measure implementation and impact of clinical guideline 11 | November 2005 |
| Survey of fertility treatments: survey two - Fertility experts, ABACUS | To measure implementation and impact of clinical guideline 11 | November 2005 |
| NICE Guidance implementation tracking, ABACUS | To track the change in utilisation of 28 technologies against expected uptake | January 2005 |
| Survey of wound care - debriding agents, ABACUS | To measure implementation and impact of technology appraisal 24 | August 2004 |
| Survey of ultrasound locating devices, ABACUS | To measure implementation and impact of technology appraisal 49 | July 2004 |
| Evaluation of NICE Guidance, University of York (external link) | To assess the extent and pattern of implementation of 12 technology appraisals issued by NICE | March 2004 |
Pharmaceutical industry reports
In addition to these commissioned evaluations, the following independent reports provide information on the use and implementation of NICE guidance:
| Publication | Purpose | Published date |
|---|---|---|
| Roche regular audits into implementation of NICE guidance | To measure progress and track NHS use of Roche products appraised by NICE | Quarterly |
| Implementation of NICE Guidance - An ABPI Perspective (Association of British Pharmaceutical Industries) | To review change in uptake on a range of drugs appraised by NICE | April 2004 |
Other reports
| Publication | Purpose | Published date |
|---|---|---|
| Managing the financial implications for NICE guidance (Audit Commission) | To identify best practice and make recommendations for improved financial management | September 2005 |
| Variations in usage of cancer drugs approved by NICE (National Cancer Director) (external link) | To examine reported variations in usage of cancer drugs across the country, identify reasons for these variations and make recommendations to ensure all appropriate patients have access to cancer drugs approved by NICE | May 2004 |
| NICE implementation - The patient organisation perspective(Breakthrough Breast Cancer Charity) | To examine the implementation of NICE guidance on trastuzumab (Herceptin) | 2002 |
